Skip to content

RIGHT IV Pilot Study

Post-Market Study Comparing the Clinical Performance Two Blood Control Safety Peripheral Intravenous Catheters: A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01792778
Acronym
RIGHT IV
Enrollment
40
Registered
2013-02-15
Start date
2013-02-28
Completion date
2013-02-28
Last updated
2016-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Intravenous Catheters

Keywords

IV Catheters, Blood control

Brief summary

The purpose of this pilot study is to collect the necessary information for determining the appropriate sample size of a statistically powered trial comparing the performance of two different blood control peripheral intravenous catheters.

Interventions

DEVICEViaValve Safety IV Catheter

Insertion of the peripheral intravenous catheters into both upper extremities of subjects

DEVICEInsyte Autoguard BC [Blood Control] Shielded IV Catheter

Sponsors

Smiths Medical, ASD, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years of age or older * Willing and able to independently sign an English Informed Consent * Have adequate veins for placement of IV catheters in both right and left upper extremities

Exclusion criteria

* Currently taking anti-coagulation medication * Have a known bloodborne disease or bleeding tendency * Have a known fear or adverse reaction to needles or blood * Women who are pregnant or nursing

Design outcomes

Primary

MeasureTime frameDescription
Clinical performance and acceptabilityIV catheters will be inserted, secured to subjects, and then immediately removed. Data regarding the insertion process will then be immediately collected.Primary outcome measure will be a composite of user ratings evaluating clinical performance and acceptability of each device via a 6-point Likert questionnaire.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026